Back to Search
Start Over
Nepafenac in cataract surgery
- Source :
- Clinicalexperimental optometry. 105(3)
- Publication Year :
- 2021
-
Abstract
- The role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in routine cataract surgery has been established since decades. Topical NSAIDs have been shown to reduce postoperative ocular inflammation and pain, preserve intraoperative mydriasis, and reduce the risk of postoperative cystoid macular oedema, whilst carrying a very low side-effect profile. Nepafenac is one of the currently available topical NSAIDs. The studies have shown that is has a high ocular penetration, allowing for potentially better results than other NSAIDs. This review gathers the current literature on the role of nepafenac in cataract surgery aiming to help surgeons maximise the benefits of its use to achieve improved surgical outcomes.
- Subjects :
- medicine.medical_specialty
genetic structures
medicine.medical_treatment
Benzeneacetamides
Ocular penetration
Cataract Extraction
Nepafenac
Cataract
Postoperative Complications
Ophthalmology
Mydriasis
medicine
Humans
Ocular inflammation
Phenylacetates
Postoperative cystoid macular oedema
business.industry
Phacoemulsification
Cataract surgery
eye diseases
sense organs
medicine.symptom
business
Optometry
medicine.drug
Subjects
Details
- ISSN :
- 14440938
- Volume :
- 105
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Clinicalexperimental optometry
- Accession number :
- edsair.doi.dedup.....88f0800facb52d9c3852ca0fce4e2391